FDA Voices
Insights from FDA leadership and experts into the agency's work to protect public health.
SPOTLIGHT: "Catching Up with Califf"
FDA’s Dietary Supplements Program Remains a Critical Priority
ODSP will remain a distinct office executing the agency’s responsibilities under the Federal Food, Drug, and Cosmetic Act for dietary supplement products.
Sub-Topic Paragraphs
Paragraph Header
FDA VOICES: PERSPECTIVES FROM FDA EXPERTS
![Photo of female health care specialist talking with pregnant woman in exam room.](https://public4.pagefreezer.com:443/content/FDA/16-09-2023T10:56/https://www.fda.gov/files/styles/medium_3/public/Medication%20Use%20in%20Pregnancy_1600x900.png?itok=lVKcsQbz)
Optimizing Postapproval Safety Studies to Expand Data Generation on Medication Use in Pregnancy
Postapproval pregnancy safety studies can help guide clinical practice and provide useful information for product labeling.
![Photo of of two people holding hands, supporting each other in difficult times.](https://public4.pagefreezer.com:443/content/FDA/16-09-2023T10:56/https://www.fda.gov/files/styles/medium_3/public/Anniversary%20of%20Overdose%20Prevention%20Framework_1600x900.png?itok=1vo3NzKs)
An Update on FDA’s Overdose Prevention Framework - Addressing Critical Areas of Need
An update on activities FDA is taking across the agency in each of the Overdose Prevention Framework priorities.
Some table information
Published Date | Image | Title | Detailed Description | Regulated Products | Health Topics (Hidden) |
---|